Isaac Israel CEO @isaac2199 Of Kitov Pharmaceuticals Discusses Targeting CEACAM1: Idea Is To Block CEACAM Connections & Doing So Gives An Immune Response.
Advertisement
Targeting CEACAM1: Idea Is To Block CEACAM Connections & Doing So Gives An Immune Response
